Intellectual Property
Jan. 26, 2010
Patent Deemed Unenforceable
A federal appeals court on Monday affirmed a ruling that an Abbott Laboratories patent for technology used in a blood-glucose measuring device is unenforceable because the company's attorney misled the U.S. Patent and Trademark Office.
Daily Journal Staff Writer
A federal appeals court on Monday affirmed a San Francisco federal judge's ruling that an Abbott Laboratories patent for technology used in a blood-glucose measuring device is unenforceable because the company's attorney misled the U.S. Patent and Trademark Office.
In a split decision, a U.S. Court of Appeals for the Federal Circuit upheld U.S. District Judge William Alsup&#...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In